SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Genetown
Drug Makers Including Genzyme Corporation and Novartis AG See Gains in Broadening their Reach; Focus Shifts to Underserved Patient Groups, Expanded Disease Targets
May 4, 2011
 · 
1 min read
Pharm Country
Novartis AG CEO Not Thrilled With Health Care Reform
May 3, 2011
 · 
1 min read
Pharm Country
Drugmakers Including Merck & Co., Inc. and Novartis AG Create Mobile Phone Apps to Track Diabetes, Cancer
February 15, 2011
 · 
1 min read
Biotech Beach
Drugmakers, Including AstraZeneca PLC, Novartis AG and Eli Lilly and Company See Pain from Reform and Prices in 2011
January 28, 2011
 · 
1 min read
Genetown
At Novartis AG, a Winning Formula
January 4, 2011
 · 
1 min read
Look Out, Your Medicine Is Watching You, Novartis AG Reveals
November 10, 2010
 · 
1 min read
FDA: Facebook Link On Novartis AG Drug Website Is Misleading
August 6, 2010
 · 
1 min read
Test Predicts Novartis AG’s Kinase Inhibitor Resistance in CML, Hokkaido University Study
July 29, 2010
 · 
1 min read
BioCapital
Fostering Pharma R&D; An Interview With Novartis AG President Mark Fishman, M.D.
June 28, 2010
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Pharm Country
Novartis Pharmaceuticals Corporation Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya
October 7, 2010
 · 
9 min read
Policy
Novartis AG Sees $590 Million Charge Because of Drug Trial Stoppages for Antifungal Agent Mycograb as Well as Zalbin
October 5, 2010
 · 
1 min read
Policy
Novartis AG Settles Off-Label Marketing Case Over 6 Drugs for $422.5 Million
October 1, 2010
 · 
1 min read
Policy
Novartis AG Strikes Back Against Alcon, Inc. IDC Legal Claims
September 30, 2010
 · 
1 min read
European Medicines Evaluation Agency Starts Safety Probe Of Common Bone Drugs Made by Roche, Merck & Co., Inc., Novartis AG and Warner Chilcott, PLC
September 24, 2010
 · 
1 min read
Deals
Warner Chilcott, PLC Agrees to Terminate Existing Co-Promotion Agreement With Novartis AG and Acquire U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash
September 24, 2010
 · 
5 min read
Drug Development
Novartis AG Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing’s Disease, a Debilitating Hormonal Disorder
September 22, 2010
 · 
11 min read
FDA
Novartis AG Gets First U.S. Approval for MS Drug Gilenya; Novartis Ahead of Merck KGaA in Race to Get to Market
September 22, 2010
 · 
1 min read
Drug Development
Novartis AG to Start China Trial of Novel Cancer Drug in 2013
September 20, 2010
 · 
1 min read
Deals
Bausch & Lomb Completes Acquisition of Miochol(R)-E from Novartis AG
September 20, 2010
 · 
1 min read
Load More